LSE - Delayed Quote GBp
Solvonis Therapeutics plc (SVNS.L)
0.1700
+0.0050
+(3.03%)
At close: 2:00:18 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
5/31/2021
5/31/2020
Total Revenue
207
587
542
520
330
Cost of Revenue
35
329
242
30
46
Gross Profit
172
258
300
490
284
Operating Expense
2,186
2,468
2,991
932
748
Operating Income
-2,014
-2,210
-2,691
-442
-464
Net Non Operating Interest Income Expense
-64
-3
-4
-7
-72
Pretax Income
-2,790
-3,120
-2,705
-451
-538
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-2,947
-3,120
-2,705
-451
-538
Diluted NI Available to Com Stockholders
-2,947
-3,120
-2,705
-451
-538
Basic EPS
-0.02
-0.03
-0.03
-0.00
-0.01
Diluted EPS
-0.02
-0.03
-0.03
-0.00
-0.01
Basic Average Shares
606,654.9800
104,057.2990
103,589.4790
104,097.2990
104,097.2990
Diluted Average Shares
2,295,930.6330
104,057.2990
103,589.4790
104,097.2990
104,097.2990
Total Operating Income as Reported
-2,858
-3,117
-2,701
-444
-352
Total Expenses
2,221
2,797
3,233
962
794
Net Income from Continuing & Discontinued Operation
-2,947
-3,120
-2,705
-451
-538
Normalized Income
-2,091
-2,282
-2,705
-451
-538
Interest Expense
64
3
4
7
72
Net Interest Income
-64
-3
-4
-7
-72
EBIT
-2,726
-3,117
-2,701
-444
-466
EBITDA
-2,679
-2,938
-2,588
-335
-352
Reconciled Cost of Revenue
35
329
242
30
46
Reconciled Depreciation
46
177
113
109
114
Net Income from Continuing Operation Net Minority Interest
-2,790
-3,120
-2,705
-451
-538
Total Unusual Items Excluding Goodwill
-699
-838
0
--
--
Total Unusual Items
-699
-838
0
--
--
Normalized EBITDA
-1,980
-2,100
-2,588
-335
-352
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
5/31/2020 - 1/6/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade